Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Dexamethasone × Clear all

Sponsor

Conditions

Multiple Myeloma 234 Precursor Cell Lymphoblastic Leukemia-Lymphoma 48 Recurrence 30 Neoplasms, Plasma Cell 27 Leukemia 25 Lymphoma 24 Vomiting 20 Neoplasms 20 Burkitt Lymphoma 19 Lymphoma, Non-Hodgkin 17 Nausea 16 Lymphoma, Mantle-Cell 16 Immunoglobulin Light-chain Amyloidosis 15 Waldenstrom Macroglobulinemia 13 Lymphoma, Follicular 13 Breast Neoplasms 13 Prostatic Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Leukemia, Myeloid, Acute 10 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Lymphocytic, Chronic, B-Cell 8 Hodgkin Disease 8 Neoplasm Metastasis 7 Amyloidosis 7 Smoldering Multiple Myeloma 6 Ovarian Neoplasms 6 Lymphoma, T-Cell, Cutaneous 5 Lung Neoplasms 5

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡